logo
Select company
Select metric
-0.1%Buyback Yield
VS
Market
38
Sector
70
Industry
84
History
85
$ 11.38Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-0.1%$ 162.04M$ 162K
3/31/2025-0.17%$ 110.73M$ 190K
12/31/2024-0.19%$ 125.01M$ 241K
9/30/2024-0.08%$ 187.15M$ 147K
6/30/2024-0.03%$ 262.1M$ 79K
3/31/2024-0.09%$ 270.25M$ 251K
12/31/2023-0.41%$ 261.49M$ 1.08M
9/30/2023-1.17%$ 189.32M$ 2.21M
6/30/2023-1.32%$ 389.95M$ 5.14M
3/31/2023-1.69%$ 537.33M$ 9.06M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) Buyback Yield stands at -1.22%.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average Buyback Yield has been -0.77%.
  • The median Buyback Yield for ENANTA PHARMACEUTICALS INC during this period was -0.69%
  • ENANTA PHARMACEUTICALS INC reached its highest Buyback Yield over the past 5 years at -0.03%.
  • The lowest Buyback Yield recorded by ENANTA PHARMACEUTICALS INC in the same timeframe -2.27%

ENANTA PHARMACEUTICALS INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
THTX : THERATECHNOLOGIES INC -BDTX : BLACK DIAMOND THERAPEUTICS INC 0.03%PLX : PROTALIX BIOTHERAPEUTICS INC -10.57%ALEC : ALECTOR INC -0.71%SGMO : SANGAMO THERAPEUTICS INC -31.98%CSBR : CHAMPIONS ONCOLOGY INC -0.3%SPRO : SPERO THERAPEUTICS INC 0%CCCC : C4 THERAPEUTICS INC -5.54%TRDA : ENTRADA THERAPEUTICS INC -0.92%CELU : CELULARITY INC -3.35%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ENANTA PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 10.48M ]) / Market Cap [ $ 862.19M ]
(=) Buyback Yield [ -1.22% ]

ENTA - Buyback Yield, Last 5 years

-2.27%

Minimum

Sep 30, 2022

-0.03%

Maximum

Jun 30, 2024

-0.77%

Average

-0.69%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.7%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.7%